{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T11:55:43Z","timestamp":1792065343965,"version":"4.4.0"},"reference-count":91,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2023,4,3]],"date-time":"2023-04-03T00:00:00Z","timestamp":1680480000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Chem Biol Drug Des"],"published-print":{"date-parts":[[2023,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Cancer is the second leading cause of death globally, with 9.6\u2009million deaths yearly. As a life\u2010threatening disease, it necessitates the emergence of new therapies. Resistance to current chemotherapies drives scientists to develop new medications that will eventually be accessible. Because heterocycles are so common in biological substances, compounds play a big part in the variety of medications that have been developed. The \u201cMaster Key\u201d is the benzimidazole nucleus, which consists of a six\u2010membered benzene ring fused with a five\u2010membered imidazole\/imidazoline ring, which is an azapyrrole. One of the five\u2010membered aromatic nitrogen heterocycles identified in American therapies that have been approved by the Food and Drug Administration (FDA). Our results show that benzimidazole's broad therapeutic spectrum is due to its structural isosteres with purine, which improves hydrogen bonding, electrostatic interactions with topoisomerase complexes, intercalation with DNA, and other functions. It also enhances protein and nucleic acid inhibition, tubulin microtubule degeneration, apoptosis, DNA fragmentation, and other functions. Additionally, readers for designing the more recent benzimidazole analogues as prospective cancer treatments.<\/jats:p>","DOI":"10.1111\/cbdd.14236","type":"journal-article","created":{"date-parts":[[2023,4,3]],"date-time":"2023-04-03T10:51:49Z","timestamp":1680519109000},"page":"357-376","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":63,"title":["Recent advances of benzimidazole as anticancer agents"],"prefix":"10.1111","volume":"102","author":[{"given":"Sneha","family":"Venugopal","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Sciences, School of Pharmacy Lovely Professional University  Punjab India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Balwinder","family":"Kaur","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, School of Pharmacy Lovely Professional University  Punjab India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil","family":"Verma","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, School of Pharmacy Lovely Professional University  Punjab India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pankaj","family":"Wadhwa","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, School of Pharmacy Lovely Professional University  Punjab India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muskan","family":"Magan","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, School of Pharmacy Lovely Professional University  Punjab India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharwan","family":"Hudda","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, School of Pharmacy Lovely Professional University  Punjab India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Violina","family":"Kakoty","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, School of Pharmacy Lovely Professional University  Punjab India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2023,4,3]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1080\/14756366.2020.1806831"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2016.12.010"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics10060728"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2017.01.045"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.biochem.8b01102"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.2174\/1385272825666210208141107"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2012.09.013"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.2174\/13895575113139990072"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2007.05.008"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20143500"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21492"},{"key":"e_1_2_8_13_1","volume-title":"Inventors: Jonathan S. Lindsey (Raleigh, NC, US) Michael Krayer (Raleigh, NC, US) assignees","author":"Class I.","year":"2014"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19082337"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1042\/BCJ20160583"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00044-016-1504-3"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1002\/slct.201904832"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2016.04.036"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.3390\/cells9020266"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1530\/JME-14-0030"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2013.00089"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1177\/1947601912458586"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2012.01.116"},{"key":"e_1_2_8_24_1","unstructured":"Haddach M.(2017).Compositions uses and methods for making them. Google Patents."},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.trac.2014.02.017"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-21-1059"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-13-0545"},{"key":"e_1_2_8_28_1","volume-title":"SEER cancer statistics review, 1975\u20132012","author":"Howlader N. N. A.","year":"2015"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.7b01202"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2017.07.011"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11224-018-1257-3"},{"key":"e_1_2_8_32_1","volume-title":"Niraparib: A poly (ADP\u2010ribose) polymerase (PARP) inhibitor for the treatment of tumors with defective homologous recombination","author":"Jones P.","year":"2015"},{"key":"e_1_2_8_33_1","doi-asserted-by":"publisher","DOI":"10.2174\/1573407214666180808124802"},{"key":"e_1_2_8_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2019.01.054"},{"key":"e_1_2_8_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinorgbio.2019.110981"},{"key":"e_1_2_8_36_1","first-page":"1","article-title":"The nano\u2010based catalyst for the synthesis of benzimidazoles","volume":"65","author":"Keri R. S.","year":"2022","journal-title":"Topics in Catalysis"},{"key":"e_1_2_8_37_1","doi-asserted-by":"publisher","DOI":"10.1021\/np800568j"},{"key":"e_1_2_8_38_1","doi-asserted-by":"publisher","DOI":"10.1002\/cmdc.202100004"},{"issue":"5","key":"e_1_2_8_39_1","first-page":"5","article-title":"Anti\u2010EGFR mechanism of action: Antitumor effect and underlying cause of adverse events","volume":"20","author":"Lenz H.\u2010J.","year":"2006","journal-title":"Oncology (Williston Park, NY)"},{"key":"e_1_2_8_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nano.2013.03.002"},{"key":"e_1_2_8_41_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-018-0654-9"},{"key":"e_1_2_8_42_1","doi-asserted-by":"publisher","DOI":"10.1097\/CCO.0000000000000164"},{"key":"e_1_2_8_43_1","doi-asserted-by":"publisher","DOI":"10.1021\/ar100140e"},{"key":"e_1_2_8_44_1","doi-asserted-by":"publisher","DOI":"10.32607\/20758251-2015-7-3-27-37"},{"key":"e_1_2_8_45_1","doi-asserted-by":"publisher","DOI":"10.1039\/C8RA02078G"},{"key":"e_1_2_8_46_1","unstructured":"Narayanan R. Miller D. D. Ponnusamy T. Hwang D.\u2010J. Duke C. B. Coss C. C. Jones A. &Dalton J. T.(2018).Selective androgen receptor degrader (SARD) ligands and methods of use thereof. Google Patents."},{"key":"e_1_2_8_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.118189"},{"key":"e_1_2_8_48_1","unstructured":"Park J. S. Yoon Y. J. Cho M. J. Lee H. B. Yoo J. K. &Lee B. Y.(2018).Heterocyclic compound method for preparing the same and pharmaceutical composition comprising the same. Google Patents."},{"key":"e_1_2_8_49_1","unstructured":"Peto C. J. Jablons D. &Lemjabbar\u2010Alaoui H.(2020).Anti\u2010cancer compounds. Google Patents."},{"key":"e_1_2_8_50_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21082967"},{"key":"e_1_2_8_51_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21114055"},{"key":"e_1_2_8_52_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1230582"},{"key":"e_1_2_8_53_1","first-page":"1","article-title":"Development of benzimidazole compounds for cancer therapy","volume":"1","author":"Purushottamachar P.","year":"2019","journal-title":"Chemistry and Applications of Benzimidazole and its Derivatives"},{"key":"e_1_2_8_54_1","unstructured":"Qian D. Han A. Q. Hamilton M. &Wang E.(2011).Phosphatidylinositol 3 kinase inhibitors. Google Patents."},{"key":"e_1_2_8_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2019.03.014"},{"key":"e_1_2_8_56_1","doi-asserted-by":"publisher","DOI":"10.1107\/S1399004714017660"},{"key":"e_1_2_8_57_1","doi-asserted-by":"publisher","DOI":"10.4155\/fmc-2017-0214"},{"key":"e_1_2_8_58_1","doi-asserted-by":"publisher","DOI":"10.3390\/molecules24061140"},{"key":"e_1_2_8_59_1","doi-asserted-by":"publisher","DOI":"10.1097\/PPO.0b013e318282635a"},{"key":"e_1_2_8_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.inoche.2020.108396"},{"key":"e_1_2_8_61_1","unstructured":"Sampson P. B. Patel N. K. B. Pauls H. W. Li S. W. Ng G. Laufer R. Liu Y. Lang Y. &University Health Network. (2019).HPK1 inhibitors and methods of using same. Google Patents."},{"key":"e_1_2_8_62_1","doi-asserted-by":"publisher","DOI":"10.1002\/jhet.4355"},{"key":"e_1_2_8_63_1","unstructured":"Schiltz G. E. Izquierdo\u2010Ferrer J. Vagadia P. Clutter M. R. Mishra R. K. &Platanias L. C.(2018).Substituted aromatic N\u2010heterocyclic compounds as inhibitors of mitogen\u2010activated protein kinase interacting kinase 1 (Mnk1) and 2 (Mnk2). Google Patents."},{"key":"e_1_2_8_64_1","unstructured":"Schultz J. V\u00e5gberg J. Olsson E. F\u00e4rneg\u00e5rdh K. J\u00f6nsson M. Hammer K. &Kr\u00fcger L.(2019).Benzimidazole derivates useful as inhibitors of mammalian histone deacetylase activity. Google Patents."},{"key":"e_1_2_8_65_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.arabjc.2013.02.001"},{"key":"e_1_2_8_66_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.talanta.2014.03.056"},{"key":"e_1_2_8_67_1","doi-asserted-by":"publisher","DOI":"10.1002\/ardp.201700040"},{"key":"e_1_2_8_68_1","unstructured":"Si J. &Jiang M.(2020).Urea compound preparation method therefor and medical use thereof. Google Patents."},{"key":"e_1_2_8_69_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21708"},{"key":"e_1_2_8_70_1","doi-asserted-by":"publisher","DOI":"10.1039\/C8OB02973C"},{"key":"e_1_2_8_71_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2019.e02596"},{"key":"e_1_2_8_72_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2015.03.012"},{"key":"e_1_2_8_73_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jphotobiol.2017.02.009"},{"key":"e_1_2_8_74_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)60919-2"},{"key":"e_1_2_8_75_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14194601"},{"key":"e_1_2_8_76_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2016.06.032"},{"key":"e_1_2_8_77_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2018.09.055"},{"key":"e_1_2_8_78_1","unstructured":"Tsang T. Peto C. Jablons D. &Alaoui H. S.(2019).Phthalazine derivatives as inhibitors of parp1 parp2 and\/or tubulin useful for the treatment of cancer. Google Patents."},{"key":"e_1_2_8_79_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrm3228"},{"key":"e_1_2_8_80_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13122872"},{"key":"e_1_2_8_81_1","doi-asserted-by":"publisher","DOI":"10.31083\/j.ceog4910227"},{"key":"e_1_2_8_82_1","doi-asserted-by":"publisher","DOI":"10.1039\/C9CS00478E"},{"key":"e_1_2_8_83_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2018.03.046"},{"key":"e_1_2_8_84_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2015.05.021"},{"key":"e_1_2_8_85_1","doi-asserted-by":"publisher","DOI":"10.2174\/138955707780859413"},{"key":"e_1_2_8_86_1","doi-asserted-by":"publisher","DOI":"10.2174\/1871520616666151103113412"},{"key":"e_1_2_8_87_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1747-0285.2012.01407.x"},{"issue":"1","key":"e_1_2_8_88_1","first-page":"26","article-title":"Targeting PBK in cancer: mechanisms and advances in clinical trials","volume":"18","author":"Yang J. N.","year":"2019","journal-title":"MolCancer"},{"key":"e_1_2_8_89_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cclet.2019.04.045"},{"key":"e_1_2_8_90_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.109661"},{"key":"e_1_2_8_91_1","doi-asserted-by":"publisher","DOI":"10.3390\/molecules25143180"},{"key":"e_1_2_8_92_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2016.03.026"}],"container-title":["Chemical Biology &amp; Drug Design"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/cbdd.14236","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,18]],"date-time":"2023-08-18T09:25:26Z","timestamp":1692350726000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/cbdd.14236"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,3]]},"references-count":91,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["10.1111\/cbdd.14236"],"URL":"https:\/\/doi.org\/10.1111\/cbdd.14236","archive":["Portico"],"relation":{},"ISSN":["1747-0277","1747-0285"],"issn-type":[{"value":"1747-0277","type":"print"},{"value":"1747-0285","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,3]]},"assertion":[{"value":"2022-10-31","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-03-14","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-04-03","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}